Cite
HARVARD Citation
Davis, C. et al. (2016). Co-prescribing naloxone does not increase liability risk. Substance abuse. 37 (4), pp. 498-500. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Davis, C. et al. (2016). Co-prescribing naloxone does not increase liability risk. Substance abuse. 37 (4), pp. 498-500. [Online].